Breakthrough therapy
id:
breakthrough-therapy-313-18225362
title:
Breakthrough therapy
text:
Breakthrough therapy is a United States Food and Drug Administration designation that expedites drug development that was created by Congress under Section 902 of the 9 July 2012 Food and Drug Administration Safety and Innovation Act. The FDA's "breakthrough therapy" designation is not intended to imply that a drug is actually a "breakthrough" or that there is high-quality evidence of treatment efficacy for a particular condition; rather, it allows the FDA to grant priority review to drug candid
brand slug:
wiki
category slug:
encyclopedia
description:
American legal mechanism
original url:
https://en.wikipedia.org/wiki/Breakthrough_therapy
date created:
date modified:
2024-02-28T17:51:29Z
main entity:
{"identifier":"Q25326544","url":"https://www.wikidata.org/entity/Q25326544"}
image:
fields total:
13
integrity:
14